Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now clearly communicates that enrollment is closed and adds new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and notes a revision to version 3.6.0, replacing the previous v3.5.5 reference.
    Difference
    0.5%
    Check dated 2026-06-13T00:31:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the document associated with the study page.
    Difference
    0.0%
    Check dated 2026-06-05T22:08:20.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 instead of v3.5.3, indicating a recent software revision. This update does not modify any study details or displayed content.
    Difference
    0.0%
    Check dated 2026-05-15T14:19:06.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updates the platform’s displayed revision number from v3.5.2 to v3.5.3 for the study details view.
    Difference
    0.0%
    Check dated 2026-04-24T05:56:37.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:12:43.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-03-19T00:15:20.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.